Amicrobe Selects Clinical Formulation for Amicidin-? PFC, Supported by Department of Defense for Prolonged Field Care of Injured Warfighters

Backed by a $3.99M Department of Defense award, issued August 2021 through MTEC, Amicidin-? PFC is intended to prevent life-threatening infections in military field settings CARLSBAD, Calif., May 10, 2022 /PRNewswire/ — Amicrobe, Inc. develops synthetic biologics with physical and…

Click here to view original post